<DOC>
	<DOCNO>NCT00003916</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell may effective treatment patient glioma . Stereotactic radiation therapy may able deliver x-ray directly tumor cause less damage normal tissue . It yet know standard radiation therapy effective follow stereotactic radiation therapy . PURPOSE : Randomized phase III trial compare effectiveness standard radiation therapy without stereotactic radiation therapy treat patient glioma .</brief_summary>
	<brief_title>Standard Radiation Therapy With Without Stereotactic Radiation Therapy Treating Patients With Glioma</brief_title>
	<detailed_description>OBJECTIVES : I . Compare effect adjuvant conventional radiotherapy without fractionated stereotactic boost radiotherapy survival patient high grade glioma . II . Compare quality life patient therapy . OUTLINE : This randomize study . Patients stratify accord WHO disease grade ( III v IV ) , center , age ( 40 vs 40 ) . Patients randomize undergo stereotactic radiotherapy treatment conventional radiotherapy . Patients undergo conventional radiotherapy twice day 6 week . Patients randomize receive additional treatment receive stereotactically guide conformal boost radiotherapy 4 day , within 4 week completion conventional radiotherapy . Quality life assess radiotherapy , follow visit . Patients follow every 3 month 1 year , every 6 month 1 year , annually thereafter . PROJECTED ACCRUAL : A total 605 patient accrue study .</detailed_description>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove WHO grade III IV glioma primary diagnosis enhance preoperative imaging Glioblastoma Anaplastic astrocytoma Gliosarcoma Tumor volume great 4.0 cm maximum diameter preoperative CT MRI No prior histology WHO grade I II glioma Astrocytoma Oligodendroglioma No brainstem infratentorial tumor No multifocal glioma Safe treat tumor stereotactically No close proximity critical structure , e.g. , optic chiasm PATIENT CHARACTERISTICS : Age : 18 65 Performance status : WHO 0 1 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Able tolerate full course conventional radiotherapy No prior concurrent medical condition would preclude study therapy No prior malignancy within 5 year except nonmelanomatous skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy No concurrent adjuvant chemotherapy Endocrine therapy : Concurrent steroid allow Radiotherapy : See Disease Characteristics No prior radiotherapy head neck area No prior radiotherapy brain No 6 week since prior radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>